| Efficacy and safety of vismodegib in advanced basal-cell carcinoma A Sekulic, MR Migden, AE Oro, L Dirix, KD Lewis, JD Hainsworth, ... New England Journal of Medicine 366 (23), 2171-2179, 2012 | 1684 | 2012 |
| Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC A Sekulic, MR Migden, K Lewis, JD Hainsworth, JA Solomon, S Yoo, ... Journal of the American Academy of Dermatology 72 (6), 1021-1026. e8, 2015 | 250 | 2015 |
| Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib ALS Chang, JA Solomon, JD Hainsworth, L Goldberg, E McKenna, B Day, ... Journal of the American Academy of Dermatology 70 (1), 60-69, 2014 | 234 | 2014 |
| Hedgehog signaling inhibitors in solid and hematological cancers JE Cortes, R Gutzmer, MW Kieran, JA Solomon Cancer treatment reviews 76, 41-50, 2019 | 123 | 2019 |
| Hedgehog pathway inhibition for the treatment of basal cell carcinoma R Gutzmer, JA Solomon Targeted Oncology 14 (3), 253-267, 2019 | 77 | 2019 |
| Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: results from UNCOVER-1, UNCOVER-2, and UNCOVER-3 A Egeberg, JJ Wu, N Korman, JA Solomon, O Goldblum, F Zhao, ... Journal of the American Academy of Dermatology 79 (1), 104-109. e8, 2018 | 58 | 2018 |
| The magnitude of COVID-19's effect on the timely management of melanoma and nonmelanoma skin cancers JW Marson, BS Maner, TP Harding, VII John Meisenheimer, JA Solomon, ... Journal of the American Academy of Dermatology 84 (4), 1100, 2021 | 57 | 2021 |
| Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials ALS Chang, ST Arron, MR Migden, JA Solomon, S Yoo, BM Day, ... Orphanet journal of rare diseases 11, 1-5, 2016 | 48 | 2016 |
| Postoperative hemorrhage risk after outpatient dermatologic surgery procedures JL O'Neill, A Taheri, JA Solomon, DJ Pearce Dermatologic Surgery 40 (1), 74-76, 2014 | 37 | 2014 |
| Evidence for membrane association of plasminogen activator activity in mouse macrophages JA Solomon, ING Chou, EW Schroder, PH Black Biochemical and Biophysical Research Communications 94 (2), 480-486, 1980 | 31 | 1980 |
| Quantifying and characterizing adverse events in dermatologic surgery JL O'Neill, YS Lee, JA Solomon, N Patel, B Shutty, SA Davis, DN Robins, ... Dermatologic Surgery 39 (6), 872-878, 2013 | 30 | 2013 |
| Accessible tumors E Klein, RA Schwartz, RW Case, OA Holtermann, J Solomon, GM Hahn Clinical immunotherapy, 31-71, 1980 | 30 | 1980 |
| Safety and efficacy of vismodegib in patients aged≥ 65 years with advanced basal cell carcinoma ALS Chang, KD Lewis, ST Arron, MR Migden, JA Solomon, S Yoo, ... Oncotarget 7 (46), 76118, 2016 | 29 | 2016 |
| Prevalence of pediatric alopecia areata among 572,617 dermatology patients CC Caldwell, SK Saikaly, RP Dellavalle, JA Solomon Journal of the American Academy of Dermatology 77 (5), 980-981, 2017 | 28 | 2017 |
| Safety and efficacy of therapies for skin symptoms of psoriasis in patients with psoriatic arthritis: a systematic review WH Boehncke, DA Martinez, JA Solomon, AB Gottlieb The Journal of rheumatology 41 (11), 2301-2305, 2014 | 26 | 2014 |
| A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 … JL Herzog, JA Solomon, Z Draelos, A Fleischer Jr, D Stough, DI Wolf, ... Journal of drugs in dermatology: JDD 10 (8), 853-860, 2011 | 25 | 2011 |
| Gaps in the understanding and treatment of skin cancer in people of color A Kailas, JA Solomon, EN Mostow, DS Rigel, R Kittles, SC Taylor Journal of the American Academy of Dermatology 74 (5), 1020-1021, 2016 | 21 | 2016 |
| Acne treatment: analysis of acne-related social media posts and the impact on patient care B Urso, KM Updyke, R Domozych, JA Solomon, I Brooks, V Burton, ... Cutis 102 (1), 41-43, 2018 | 17 | 2018 |
| Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (aBCC): 24-month update of the pivotal ERIVANCE BCC study A Sekulic, MR Migden, AE Oro, L Dirix, K Lewis, JD Hainsworth, ... Pigment Cell Melanoma Res 26, 999, 2013 | 15 | 2013 |
| Stimulation of plasminogen activator expression and induction of DNA synthesis by microtubule-disruptive drugs ING Chou, J Zeiger, JA Solomon, PH Black Biochemical and Biophysical Research Communications 101 (4), 1266-1273, 1981 | 15 | 1981 |
